CEPA VIVA ATENUADA DE STAPHYLOCOCCUS AUREUS COMO VACUNA EN MASTITIS DE RUMIANTES

The invention relates to the use of an attenuated live strain of Staphylococcus aureus

Saved in:
Bibliographic Details
Main Authors MARTINEZ PULGARIN SUSANA, DE LA FUENTE LOPEZ RICARDO, ORDEN GUTIERREZ JOSE ANTONIO, RUIZ SANTA-QUITERIA JOSE ANTONIO, DOMINGUEZ BERNAL GUSTAVO, CID VAZQUEZ DOLORES
Format Patent
LanguageSpanish
Published 17.06.2009
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the use of an attenuated live strain of Staphylococcus aureus
Bibliography:Application Number: ES20050000809